Blood Advances (Jul 2018)
Human adult HSCs can be discriminated from lineage-committed HPCs by the expression of endomucin
- Kristian Reckzeh,
- Hüsün Kizilkaya,
- Alexandra Søgaard Helbo,
- Montserrat Estruch Alrich,
- André Gundersen Deslauriers,
- Amit Grover,
- Nicolas Rapin,
- Fazila Asmar,
- Kirsten Grønbæk,
- Bo Porse,
- Niels Borregaard,
- Dietmar Vestweber,
- Claus Nerlov,
- Kim Theilgaard-Mönch
Affiliations
- Kristian Reckzeh
- Finsen Laboratory, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Biotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;
- Hüsün Kizilkaya
- Finsen Laboratory, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Biotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;
- Alexandra Søgaard Helbo
- Finsen Laboratory, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Biotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;
- Montserrat Estruch Alrich
- Finsen Laboratory, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Biotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;
- André Gundersen Deslauriers
- Finsen Laboratory, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Biotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Department of Epidemiology and Statistics, Memorial Sloan Kettering Cancer Center, New York, NY;; Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;
- Amit Grover
- MRC Molecular Hematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom;
- Nicolas Rapin
- Finsen Laboratory, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Biotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Bioinformatics Centre, Department of Biology, University of Copenhagen, Copenhagen, Denmark;
- Fazila Asmar
- Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;
- Kirsten Grønbæk
- Biotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;
- Bo Porse
- Finsen Laboratory, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Biotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;
- Niels Borregaard
- Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;
- Dietmar Vestweber
- Max Planck Institute for Molecular Biomedicine, University of Münster, Münster, Germany
- Claus Nerlov
- MRC Molecular Hematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom;
- Kim Theilgaard-Mönch
- Finsen Laboratory, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Biotech Research and Innovation Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark;; Department of Hematology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;; Kim Theilgaard-Mönch, Department of Hematology & Finsen Laboratory, National University Hospital and Biotech Research and Innovation Centre, University of Copenhagen, Ole Maaloes Vej 5, 2200 Copenhagen, Denmark;
- Journal volume & issue
-
Vol. 2,
no. 13
pp. 1628 – 1632